Protagonist Therapeutics (PTGX)
(Delayed Data from NSDQ)
$37.83 USD
+1.08 (2.94%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $37.58 -0.25 (-0.66%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.50 |
EPS Last Quarter | 3.26 |
Last EPS Surprise | 29.88% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 2.28 |
Next Year | -0.85 |
EPS (TTM) | 2.44 |
P/E (F1) | 16.12 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 40.00M | 5.00M | 309.99M | 117.23M |
# of Estimates | 1 | 1 | 4 | 4 |
High Estimate | 40.00M | 5.00M | 395.00M | 330.00M |
Low Estimate | 40.00M | 5.00M | 254.95M | 15.00M |
Year ago Sales | 0.00M | 0.00M | 60.00M | 309.99M |
Year over Year Growth Est. | NA | NA | 416.65% | -62.18% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.50 | -0.64 | 2.28 | -0.85 |
# of Estimates | 4 | 4 | 3 | 4 |
Most Recent Consensus | -0.64 | -0.64 | 1.30 | 1.74 |
High Estimate | 0.05 | -0.49 | 3.23 | 1.74 |
Low Estimate | -0.74 | -0.75 | 1.30 | -2.88 |
Year ago EPS | -0.68 | -0.58 | -1.39 | 2.28 |
Year over Year Growth Est. | 26.47% | -10.34% | 264.03% | -137.06% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.50 | -0.64 | 2.28 | -0.85 |
7 Days Ago | -0.50 | -0.64 | 2.28 | -0.85 |
30 Days Ago | -0.50 | -0.64 | 2.28 | -0.85 |
60 Days Ago | -0.50 | -0.64 | 1.66 | -0.46 |
90 Days Ago | -0.62 | -0.63 | 0.83 | -0.97 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.50 | -0.64 | 2.28 | -0.85 |
Zacks Consensus Estimate | -0.50 | -0.64 | 2.28 | -0.85 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 3.26 | 0.44 | -0.58 | -0.68 | NA |
Estimate | 2.51 | -0.16 | -0.68 | -0.65 | NA |
Difference | 0.75 | 0.60 | 0.10 | -0.03 | 0.36 |
Surprise | 29.88% | 375.00% | 14.71% | -4.62% | 103.74% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more